Structures by: Nugraha Y. P.
Total: 8
Amodiaquine Dihydrochloride Dihydrate
C20H24ClN3O,2(Cl),2(H2O)
CrystEngComm (2019) 21, 13 2053
a=7.69610(14)Å b=10.9153(2)Å c=27.2368(5)Å
α=90° β=96.1341(7)° γ=90°
Metoclopramide hydrochloride oxalic acid
C14H23ClN3O2,0.5(C2H2O4),Cl
CrystEngComm (2018) 20, 19 2653
a=7.5270(4)Å b=14.1483(9)Å c=34.3682(19)Å
α=90° β=90° γ=90°
Metoclopramide HCl Monohydrate
C14H23ClN3O2,Cl,H2O
CrystEngComm (2018) 20, 19 2653
a=12.1124(17)Å b=8.5524(12)Å c=16.849(3)Å
α=90° β=98.605(7)° γ=90°
Metoclopramide HCl anhydrate
C14H23ClN3O2,Cl
CrystEngComm (2018) 20, 19 2653
a=14.6866(4)Å b=7.0245(2)Å c=33.0316(9)Å
α=90° β=90° γ=90°
Epalerstat. DMF solvate
C15H13NO3S2,C3H7NO
CrystEngComm (2017)
a=7.6999(3)Å b=8.7601(3)Å c=15.1662(5)Å
α=102.148(7)° β=95.754(7)° γ=110.011(8)°
2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]
C8H10N4O2,C15H13NO3S2
CrystEngComm (2017)
a=7.7900(4)Å b=8.4073(4)Å c=19.8594(10)Å
α=84.159(3)° β=88.907(2)° γ=62.877(3)°
Epalerstat. 2 DMSO
C15H13NO3S2,2(C2H6OS)
CrystEngComm (2017)
a=8.0773(2)Å b=9.3224(2)Å c=16.0729(3)Å
α=99.322(7)° β=91.404(6)° γ=108.099(8)°
Olivetolic acid
C12H16O4
Acta Crystallographica Section E (2016) 72, 11 1587-1589
a=14.2527(8)Å b=4.7524(3)Å c=17.6489(11)Å
α=90° β=103.538(4)° γ=90°